Doctor profile · Federal record

Dr. Benjamin Kretzmann, M.D.

Rheumatology Physician (CMS: Rheumatology) · Los Angeles, CA

  • NPI 1881824399
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 17 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8700 Beverly Blvd Rm 5512
Los Angeles, CA 90048
(310) 423-5161
Additional location
8640 W 3Rd St Ste 300
Los Angeles, CA 900483386
(310) 659-7878
Mailing address
8640 W 3Rd St Ste 300
Los Angeles, CA 900483386

Credentials & registration

NPPES · NUCC
NPI registered
July 2009 — 17 yrs on file
Profile last updated
February 28, 2022
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #A116280

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1881824399. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
46,681
Distinct HCPCS
10
Medicare allowed
$798,531
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 22,800 11 $5
J0897 Injection, denosumab, 1 mg 7,393 85 $23
J1602 Injection, golimumab, 1 mg, for intravenous use 5,750 12 $13
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,062 11 $33
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 1,113 121 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 680 290 $141
36415 Insertion of needle into vein for collection of blood sample 526 239 $8
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated 390 171 $4
86140 Measurement c-reactive protein for detection of infection or inflammation 390 171 $5
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 386 168 $8

In context: peer comparison

Among 20 peers in this city , average services per provider: 599. This provider delivers 78× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$88
Transactions
4
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 4 $87.83

By nature of payment

Food and Beverage
$88

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
691
Patients
171
Total drug cost
$210,314
Drug Type Claims Patients Total cost
Duloxetine Hcl Generic 111 24 $2,298
Gabapentin Generic 105 34 $1,699
Prednisone Generic 75 27 $710
Leflunomide Generic 71 19 $4,986
Hydroxychloroquine Sulfate Generic 57 14 $2,592
Methotrexate (Methotrexate Sodium) Brand 41 12 $1,227
Tizanidine Hcl Generic 39 18 $809
Tramadol Hcl Generic 35 12 $231
Celecoxib Generic 29 11 $1,641
Allopurinol Generic 27 0 $317

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Benjamin Kretzmann's medical specialty?
Dr. Benjamin Kretzmann practices Rheumatology Physician in Los Angeles, CA.
Where does Dr. Benjamin Kretzmann practice?
Dr. Benjamin Kretzmann practices at 8700 Beverly Blvd Rm 5512, Los Angeles, CA 90048. Office phone: 3104235161.
What is Dr. Benjamin Kretzmann's NPI?
Dr. Benjamin Kretzmann's National Provider Identifier (NPI) is 1881824399, issued by NPPES.
Does Dr. Benjamin Kretzmann accept Medicare assignment?
Yes. Dr. Benjamin Kretzmann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Benjamin Kretzmann commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.